胸肌前直埋乳房重建的安全结局与风险因素
本研究回顾性比较114例胸肌前与142例胸肌后直埋乳房重建患者,采用惩罚逻辑回归分析并发症与风险因素,发现两组在血清肿、复发、取出、包膜挛缩、皮瓣坏死、感染、血肿和修整方面安全性相当,胸肌前直埋可作为胸肌后直埋的安全替代。
要点
- 胸肌前直埋与胸肌后直埋乳房重建安全性指标相当
- 皮瓣条件良好时可考虑胸肌前直埋以消除动画畸形
- 术后并发症与协变量风险因素的关系经惩罚逻辑回归评估
核心结论
- 胸肌前直埋乳房重建是胸肌后直埋的安全替代方案。
研究设计与样本
- 回顾性图表综述,由五名外科肿瘤学家和两名整形外科医生团队实施。
- 比较114例胸肌前直埋与142例胸肌后直埋乳房重建患者队列。
- 采用单变量分析比较队列间患者特征,并构建惩罚逻辑回归模型识别并发症与协变量风险因素的关系。
主要发现
- 惩罚回归模型显示胸肌前与胸肌后直埋乳房重建在安全性指标上等效,包括血清肿(p = 0.0883)、癌症复发(p = 0.876)、取出(p = 0.992)、包膜挛缩(p = 0.158)、乳房切除皮瓣坏死(p = 0.769)、感染(p = 0.523)、血肿(p = 0.228)和修整(p = 0.122)。
临床怎么用
- 当乳房切除皮瓣条件良好时,应考虑胸肌前直埋乳房重建,因其发病率低且可消除动画畸形。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Continued evolution of implant-based breast reconstruction involves immediate placement of the implant above the pectoralis muscle. The shift to prepectoral breast reconstruction is driven by goals of decreasing morbidity such as breast animation deformity, range-of-motion problems, and pain, and is made possible by improvements in mastectomy skin flap viability. To define clinical factors to guide patient selection for direct-to-implant prepectoral implant reconstruction, this study compares safety endpoints and risk factors between prepectoral and subpectoral direct-to-implant breast reconstruction cohorts. The authors hypothesized that prepectoral direct-to-implant breast reconstruction is a safe alternative to subpectoral direct-to-implant breast reconstruction. METHODS: Retrospective chart review identified patients who underwent prepectoral and subpectoral direct-to-implant breast reconstruction, performed by a team of five surgical oncologists and two plastic surgeons. Univariate analysis compared patient characteristics between cohorts. A penalized logistic regression model was constructed to identify relationships between postoperative complications and covariate risk factors. RESULTS: A cohort of 114 prepectoral direct-to-implant patients was compared with 142 subpectoral direct-to-implant patients. The results of the penalized regression model demonstrated equivalence in safety metrics between prepectoral direct-to-implant and subpectoral direct-to-implant breast reconstruction, including seroma (p = 0.0883), cancer recurrence (p = 0.876), explantation (p = 0.992), capsular contracture (p = 0.158), mastectomy skin flap necrosis (p = 0.769), infection (p = 0.523), hematoma (p = 0.228), and revision (p = 0.122). CONCLUSIONS: This study demonstrates that prepectoral direct-to-implant reconstruction is a safe alternative to subpectoral direct-to-implant reconstruction. Given the low morbidity and elimination of animation deformity, prepectoral direct-to-implant reconstruction should be considered when the mastectomy skin flap is robust. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Nealon KP, Weitzman RE, Sobti N, et al. Prepectoral Direct-to-Implant Breast Reconstruction: Safety Outcome Endpoints and Delineation of Risk Factors. Plast Reconstr Surg. 2020. PMID: 32332523. doi:10.1097/PRS.0000000000006721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。